Φοιτητής του Oxford θα θεραπεύσει την καράφλα;
- Έναρξη μίζας Άκης
- Ημερομηνία έναρξης
- Κατάσταση
Παρακαλώ συνδεθείτε ή εγγραφείτε για να απενεργοποιήσετε τις διαφημίσεις.
giannis1991
Well-Known Member
Απ: Φοιτητής του Oxford θα θεραπεύσει την καράφλα;
οχι ρε συ genesis....δες πιο πανω...ο τριανταφυλλος το μετεμψυχωσε
αναρ τι να μαθω?κακο θα ηταν αν εγραφα κατι που ειναι απο πιο παλια αν για μενα ειχε ενδιαφερον?
genesis είπε:Ο giannis13 έχει τη μαγικη ικανοτητα να ανασταινει απο τις σταχτες τους καμμενα και προπολεμικα θεματα...
οχι ρε συ genesis....δες πιο πανω...ο τριανταφυλλος το μετεμψυχωσε αναρ τι να μαθω?κακο θα ηταν αν εγραφα κατι που ειναι απο πιο παλια αν για μενα ειχε ενδιαφερον?
giannis1991
Well-Known Member
Απ: Φοιτητής του Oxford θα θεραπεύσει την καράφλα;
ναι ρε σιγα...δεν παρεξηγω....απλα ετσι το ειπα μηπως πειραζει(ποτε δεν ξερεις) ;D
ANAR είπε:
ναι ρε σιγα...δεν παρεξηγω....απλα ετσι το ειπα μηπως πειραζει(ποτε δεν ξερεις) ;D
giannis1991
Well-Known Member
Απ: Φοιτητής του Oxford θα θεραπεύσει την καράφλα;
απλα το ειπα γτ σε ειδα που ξαναανοιξες κανα 2 θεματακια πολυυυυυ παλια ...(οχι το συγκεκριμενο βεβαια..λαθος μου).
[/quote]
ναι οντως...εχεις δικιο σε αυτο.τωρα προσφατα ανοιξα κατι παλιααααα θεματα....
αλλα απλα εψαχνα και ειχα τις ερωτησεις μου....
κακο θα ηταν αν δεν το εγραφες...genesis είπε:
απλα το ειπα γτ σε ειδα που ξαναανοιξες κανα 2 θεματακια πολυυυυυ παλια ...(οχι το συγκεκριμενο βεβαια..λαθος μου).
[/quote]
ναι οντως...εχεις δικιο σε αυτο.τωρα προσφατα ανοιξα κατι παλιααααα θεματα....
αλλα απλα εψαχνα και ειχα τις ερωτησεις μου....
NoMoreLoss
New Member
Απ: Φοιτητής του Oxford θα θεραπεύσει την καράφλα;
Welcome to the TRX2 rejuveNation community!
TRX2 is a brand new research project, exclusively devoted to providing a new standard of care for the treatment of Androgenetic Alopecia. Current treatments for AGA are outdated and fail to address many of the major concerns of the hair loss community. Simply put, the medical establishment has not kept up with the increased demand for truly effective solutions.
For many years researchers have turned a blind eye to the hundreds of millions of men and women across the world actively battling AGA. Most companies see baldness as a condition to be exploited rather than a problem that needs to be solved. At Oxford Biolabs, the company behind TRX2, we fully believe in the potential of our products to change the way people handle their hair loss.
We have finalized pre-clinical trials and will enter clinical studies in several distinct areas of focus - the results to date are promising:
1) Hair restoration and re-growth
2) The prevention of hair loss
3) A cure against AGA
Our research implements a completely novel technology, which will take time and will continue to being developed in stealth. Initial results may be provided to the public during 2010. Please understand that we are not able to respond to any emails with questions related to our research and/or products at this stage. Your continued subscription to our newsletter will guarantee that you receive the most up-to-date information regarding these trials.
However, we are not all secretly. In fact our approach is radically different than any other company performing research into this area. Instead of working independently and neglecting public concern, we have chosen to embrace it!
The rejuvenation community provides us with the opportunity to actively engage our customer base through an open and honest internet medium. We strongly encourage you to become involved in this process! You can use the website to send us interesting articles, stories, regimens, photos, videos, questions and your own ideas. We are all ear. If you wish, your input will be published on our website and will help millions of other people around the world as they grapple with the pervasive problem of hair loss.
Your participation in this movement is vitally important to us! We’ve loaded up our website with information and discussion topics. Your unique additions will help keep us focused, driven and motivated to succeed in this important endeavor. There are plenty of ways to join our community:
o Follow us on Twitter
o Become a fan on Facebook.
o Sign up to receive our monthly health journal (coming soon).
o Subscribe to our blog via Email or RSS
o Subscribe to our Premium Membership for additional benefits, customized recommendations and early access to our upcoming products.
o Establish a personality on our website by providing us with your insights and active involvement
We have commercialized the website to a certain degree, e.g. by introducing a membership scheme (no worry, for now you can “Pay what you want”) or linking to an affiliate store at amazon. This will not only add value to your experience as a member but also will allow us to cover the additional costs of providing & improving this service to you. 50% goes to the maintaining and improving the site and 50% towards our Research and Development.
The extremely large volume of e-mails we've received in recent months has rendered us incapable of responding to inquiries on an individual basis. This enhanced infrastucture will enable us to respond in a more diligent and efficient manner to the concerns of our community members. Make no mistake, communication is vital to the long-term success of our company and we will do our best to provide as much information to interested parties as possible.
With research facilities in Oxford, UK and Regensburg, Germany, the development of TRX2 is truly a collaborative effort. Our team of dedicated professionals is working tirelessly to bring our treatments to market as quickly and efficiently as possible. The interim period can be filled with the uncertainty and frustration many have come to accept from this industry, or it can be filled with perseverance, information and optimism. We’ve chosen the latter!
Thanks for joining us in our fight to end hair loss as we know it.
Visit TRX2 rejuvenation!
Best regards,
The TRX2 Team
[email protected]
αυτό είναι το mail που μου έστειλαν
Welcome to the TRX2 rejuveNation community!
TRX2 is a brand new research project, exclusively devoted to providing a new standard of care for the treatment of Androgenetic Alopecia. Current treatments for AGA are outdated and fail to address many of the major concerns of the hair loss community. Simply put, the medical establishment has not kept up with the increased demand for truly effective solutions.
For many years researchers have turned a blind eye to the hundreds of millions of men and women across the world actively battling AGA. Most companies see baldness as a condition to be exploited rather than a problem that needs to be solved. At Oxford Biolabs, the company behind TRX2, we fully believe in the potential of our products to change the way people handle their hair loss.
We have finalized pre-clinical trials and will enter clinical studies in several distinct areas of focus - the results to date are promising:
1) Hair restoration and re-growth
2) The prevention of hair loss
3) A cure against AGA
Our research implements a completely novel technology, which will take time and will continue to being developed in stealth. Initial results may be provided to the public during 2010. Please understand that we are not able to respond to any emails with questions related to our research and/or products at this stage. Your continued subscription to our newsletter will guarantee that you receive the most up-to-date information regarding these trials.
However, we are not all secretly. In fact our approach is radically different than any other company performing research into this area. Instead of working independently and neglecting public concern, we have chosen to embrace it!
The rejuvenation community provides us with the opportunity to actively engage our customer base through an open and honest internet medium. We strongly encourage you to become involved in this process! You can use the website to send us interesting articles, stories, regimens, photos, videos, questions and your own ideas. We are all ear. If you wish, your input will be published on our website and will help millions of other people around the world as they grapple with the pervasive problem of hair loss.
Your participation in this movement is vitally important to us! We’ve loaded up our website with information and discussion topics. Your unique additions will help keep us focused, driven and motivated to succeed in this important endeavor. There are plenty of ways to join our community:
o Follow us on Twitter
o Become a fan on Facebook.
o Sign up to receive our monthly health journal (coming soon).
o Subscribe to our blog via Email or RSS
o Subscribe to our Premium Membership for additional benefits, customized recommendations and early access to our upcoming products.
o Establish a personality on our website by providing us with your insights and active involvement
We have commercialized the website to a certain degree, e.g. by introducing a membership scheme (no worry, for now you can “Pay what you want”) or linking to an affiliate store at amazon. This will not only add value to your experience as a member but also will allow us to cover the additional costs of providing & improving this service to you. 50% goes to the maintaining and improving the site and 50% towards our Research and Development.
The extremely large volume of e-mails we've received in recent months has rendered us incapable of responding to inquiries on an individual basis. This enhanced infrastucture will enable us to respond in a more diligent and efficient manner to the concerns of our community members. Make no mistake, communication is vital to the long-term success of our company and we will do our best to provide as much information to interested parties as possible.
With research facilities in Oxford, UK and Regensburg, Germany, the development of TRX2 is truly a collaborative effort. Our team of dedicated professionals is working tirelessly to bring our treatments to market as quickly and efficiently as possible. The interim period can be filled with the uncertainty and frustration many have come to accept from this industry, or it can be filled with perseverance, information and optimism. We’ve chosen the latter!
Thanks for joining us in our fight to end hair loss as we know it.
Visit TRX2 rejuvenation!
Best regards,
The TRX2 Team
[email protected]
αυτό είναι το mail που μου έστειλαν
Απ: Φοιτητής του Oxford θα θεραπεύσει την καράφλα;
κατα την αποψη μου ενα τεραστιο λαμογιο που προσπαθει να δημιουργησει traffic στο site του με παραμυθια για θεραπειες...πουλαει και διαφορα απο το site θελει και donations τα παιρνει και απο τις διαφημισεις. Μιας πρωτης ταξεως απατη και οποτε κανετε κλικ στο link του δικαιολογειτε το λογο που την εφτιαξε και τον κανετε και λιγο πιο πλουσιο και μαγκα που μας κοροιδευει και βγαζει λεφτα
κατα την αποψη μου ενα τεραστιο λαμογιο που προσπαθει να δημιουργησει traffic στο site του με παραμυθια για θεραπειες...πουλαει και διαφορα απο το site θελει και donations τα παιρνει και απο τις διαφημισεις. Μιας πρωτης ταξεως απατη και οποτε κανετε κλικ στο link του δικαιολογειτε το λογο που την εφτιαξε και τον κανετε και λιγο πιο πλουσιο και μαγκα που μας κοροιδευει και βγαζει λεφτα
NoMoreLoss
New Member
Απ: Φοιτητής του Oxford θα θεραπεύσει την καράφλα;
μέσα είσαι @hope Αγγλοι ρε φίλε οι χειρότεροι των Ευρωπαίων λαμόγια και @δ3ρφ3ς. Πιστευω ότι φούσκα είναι και θα σκάσει και το πιστευω ακράδαντα!!!
μέσα είσαι @hope Αγγλοι ρε φίλε οι χειρότεροι των Ευρωπαίων λαμόγια και @δ3ρφ3ς. Πιστευω ότι φούσκα είναι και θα σκάσει και το πιστευω ακράδαντα!!!
Παρακαλώ συνδεθείτε ή εγγραφείτε για να απενεργοποιήσετε τις διαφημίσεις.
NoMoreLoss
New Member
Απ: Φοιτητής του Oxford θα θεραπεύσει την καράφλα;
ANAR το Λονδίνο είναι η φωλιά του φούστη έστι δεν είναι?
ANAR το Λονδίνο είναι η φωλιά του φούστη έστι δεν είναι?
giannis1991
Well-Known Member
Απ: Φοιτητής του Oxford θα θεραπεύσει την καράφλα;
http://piraeuspress.gr/index.php?option=com_content&view=article&id=2395:----transstem&catid=97:2009-03-02-18-43-24&Itemid=141
http://news.kathimerini.gr/4dcgi/_w_articles_world_2_17/01/2004_90530
http://www.ethnos.gr/article.asp?catid=11387&subid=2&tag=8334&pubid=1076440
http://piraeuspress.gr/index.php?option=com_content&view=article&id=2395:----transstem&catid=97:2009-03-02-18-43-24&Itemid=141
http://news.kathimerini.gr/4dcgi/_w_articles_world_2_17/01/2004_90530
http://www.ethnos.gr/article.asp?catid=11387&subid=2&tag=8334&pubid=1076440
Απ: Φοιτητής του Oxford θα θεραπεύσει την καράφλα;
μακαρι................ρε γιαννη :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper
μακαρι................ρε γιαννη :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper :worshipper
dimitris1991
Member
Απ: Φοιτητής του Oxford θα θεραπεύσει την καράφλα;
του 2004 αρθρα
αλλα ναι μακαρι
του 2004 αρθρα
αλλα ναι μακαρι
Απ: Φοιτητής του Oxford θα θεραπεύσει την καράφλα;
αυτο του εθνους ειναι του 2008.... ;D
η εταιρεια......που ξεκινησε τις ερευνες...σταματησε.....και πουληθηκε στη pfizer........και περα απο αυτο λεει οτι απετυχε....
Millions of hair loss sufferers worldwide hold high hopes that hair multiplication (HM) will be the baldness cure of the near future. Hair cloning may eventually provide balding men and women with an unlimited supply of their own natural hair to end baldness once and for all. Unfortunately, Intercytex is closing its doors after a long uphill battle to develop this future hair loss treatment.
Intercytex is a UK based company and was a major contender in developing hair multiplication/cloning. They’ve also been developing other treatments including those for wound healing, wrinkles, and blindness. In addition to slashing overheads and reducing staff, Intercytex sold the assets of its subsidiary Axordia to Pfizer in an attempt to support working capital. Unfortunately, the amount was inadequate to stay in business and no other funding was obtainable. Their stock which at one time traded for over $100 per share has slumped down to $4 per share and is now virtually worthless since the company is being dissolved.
Patrick Hennessey, publisher of the Hair Transplant Network visited Intercytex’s hair multiplication operation in Manchester, England when he visited the Farjo Clinic back in May of 2007. While they appeared to have good management and promising preliminary results, their subsequent Phase II testing on humans failed to produce cosmetically significanthair regrowth. It’s suggested that the key to success may lie in growing stem cells in vitro to a hair follicle stage and then transplanting the hair follicles using today’s state of the art surgical hair restoration techniques.
Intercytex intends to sell the majority of its remaining assets including their hair multiplication/cloning research, wound healing agents, and anti-aging agent Vavelta over the next few months. Who if anyone, will be responsible for continuing research performed by Intercytex in developing hair multiplication is unknown at this time.
http://www.intercytex.com/icx/products/aesthetic/icxtrc/
αυτο του εθνους ειναι του 2008.... ;D
η εταιρεια......που ξεκινησε τις ερευνες...σταματησε.....και πουληθηκε στη pfizer........και περα απο αυτο λεει οτι απετυχε....
Millions of hair loss sufferers worldwide hold high hopes that hair multiplication (HM) will be the baldness cure of the near future. Hair cloning may eventually provide balding men and women with an unlimited supply of their own natural hair to end baldness once and for all. Unfortunately, Intercytex is closing its doors after a long uphill battle to develop this future hair loss treatment.
Intercytex is a UK based company and was a major contender in developing hair multiplication/cloning. They’ve also been developing other treatments including those for wound healing, wrinkles, and blindness. In addition to slashing overheads and reducing staff, Intercytex sold the assets of its subsidiary Axordia to Pfizer in an attempt to support working capital. Unfortunately, the amount was inadequate to stay in business and no other funding was obtainable. Their stock which at one time traded for over $100 per share has slumped down to $4 per share and is now virtually worthless since the company is being dissolved.
Patrick Hennessey, publisher of the Hair Transplant Network visited Intercytex’s hair multiplication operation in Manchester, England when he visited the Farjo Clinic back in May of 2007. While they appeared to have good management and promising preliminary results, their subsequent Phase II testing on humans failed to produce cosmetically significanthair regrowth. It’s suggested that the key to success may lie in growing stem cells in vitro to a hair follicle stage and then transplanting the hair follicles using today’s state of the art surgical hair restoration techniques.
Intercytex intends to sell the majority of its remaining assets including their hair multiplication/cloning research, wound healing agents, and anti-aging agent Vavelta over the next few months. Who if anyone, will be responsible for continuing research performed by Intercytex in developing hair multiplication is unknown at this time.
http://www.intercytex.com/icx/products/aesthetic/icxtrc/
giannis1991
Well-Known Member
Απ: Φοιτητής του Oxford θα θεραπεύσει την καράφλα;
εννοειται μακαρι...εγω ετσι τα εβαλα...τα βρηκα και τα εβαλα.....παντως εχουν αρχισει τα πειραματα εδω και λιγα χρονια και αυτο ειναι καλο......εγω παντως ειμαι πολυ αισιοδοξος οτι θα γινει κατι απλα δεν ξερω αν θα προωθηθει λογω των συμφεροντων.....γιατι π.χ σε ενα αρθρο λεει οτι ο πληθυσμος της αμερικης ξοδευει 1,5 δις δολαρια σε μεταμοσχευσιεις και φαρμακα για τα μαλλια.....
εννοειται μακαρι...εγω ετσι τα εβαλα...τα βρηκα και τα εβαλα.....παντως εχουν αρχισει τα πειραματα εδω και λιγα χρονια και αυτο ειναι καλο......εγω παντως ειμαι πολυ αισιοδοξος οτι θα γινει κατι απλα δεν ξερω αν θα προωθηθει λογω των συμφεροντων.....γιατι π.χ σε ενα αρθρο λεει οτι ο πληθυσμος της αμερικης ξοδευει 1,5 δις δολαρια σε μεταμοσχευσιεις και φαρμακα για τα μαλλια.....
- Κατάσταση